Subcutaneous interleukin-2 and interferon alfa administration in patients with metastatic renal cell carcinoma: final results of SCAPP III, a large, multicenter, phase II, nonrandomized study with sequential analysis design--the Subcutaneous Administration Propeukin Program Cooperative Group.
Source:http://linkedlifedata.com/resource/pubmed/id/14581421
J. Clin. Oncol.
2003
Nov
1
21
21
3987-94
